NCT06671548: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
- State
- Under way
- Phase
- Phase 3
- People
- 120 planned
- Started
- 15 Jan 2024
- Primary completion
- 12 Nov 2026
- Arms
- Relugolix plus megestrol acetate/medroxyprogesterone acetate (the treatment group)
- Results
- None posted
- 15 Jan 2024: Trial started
- 4 Nov 2024: Trial registered